Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Schindlmaier Katharina |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Leithner, K; Schindlmaier, K Metabolic adaptation in (lung) macrophages
8. Grazer Lungentag; NOV 5, 2024; Graz. 2024. [Oral Communication]

 

Schindlmaier, K; Haitzmann, T; Bluemel, G; Rittchen, S; Jäger, V; Dengler, M; Kargl, J; Leithner, K; Macrophages flexibly use variable carbon sources and activate gluconeogenesis upon glucose starvation, while maintaining their phenotype.
5th Metabolism and Cancer ; NOV 22-24, 2023; Nice, FRANCE. 2023. [Poster]

 

Schindlmaier, K; Haitzmann, T; Bluemel, G; Rittchen, S; Kargl, J; Leithner, K; Gluconeogenesis is activated in macrophages under glucose starvation.
Doctoral Day of the Medical University of Graz; FEB 9, 2023; Graz, AUSTRIA. 2023. [Poster]

 

Krstic, J; Reinisch, I; Schindlmaier K; Galhuber M; Zenezini Chiozzi, R; Heck, AJR; Huch, M; Malli, R; Prokesch, A Curtailing metabolic flexibility by fasting to overcome sorafenib resistance in hepatocellular carcinoma
Abstract book. 2022; -ÖeGHO Frühjahrstagung; MÄRZ 3-5, 2022; Graz, Austria. [Oral Communication]

 

Schindlmaier, K; Haitzmann, T; Bluemel, G; Rittchen, S; Kargl, J; Leithner, K Adaptive responses of cancer cells and macrophages to glucose deprivation.
Type 2 Immunity in Homeostasis and Disease (2nd edition); DEC 12-14, 2022; Ghent, BELGIUM;. 2022. [Poster]
FullText

 

Krstic, J; Reinisch, I; Schindlmaier, K; Galhuber, G; Nössing, C; Depaoli, MR; Ramadani-Muja, J; Zenezini Chiozzi, R; Grinninger, L; Feichtinger, J; Klymiuk, I; Heitzer, E; Heck, AJR; Huch, M; Malli, R; Prokesch, A Overcoming hepatocellular cancer drug resistance by targeting metabolic flexibility confered by p53
https://virtual.keystonesymposia.org/ks/. 2021; -Keystone Symposium on Hepatobiliary Cancers (EK29); March 22-24, 2021; https://virtual.keystonesymposia.org/ks/. [Oral Communication]
FullText

 

Krstic, J; Reinisch, I; Schindlmaier, K; Galhuber, G; Nössing, C; Depaoli, MR; Ramadani-Muja, J; Zenezini Chiozzi, R; Heck, AJR; Huch, M; Malli, R; Prokesch, A Overcoming sorafenib resistance in hepatocellular carcinoma by curtailing metabolic flexibility
Cell Symposia: Overcoming therapy resistance; NOV 8-10, 2021; Barcelona, Spain. 2021. [Poster]

 

Krstic, J; Reinisch, I; Schindlmaier, K; Galhuber, G; Nössing, C; Depaoli, MR; Ramadani-Muja, J; Zenezini Chiozzi, R; Heck, AJR; Huch, M; Malli, R; Prokesch, A Fasting curtails metabolic flexibility to sensitize hepatocellular carcinoma to sorafenib
Virtual Keystone Symposium "Precision oncology: Translating Discovery to the Clinic"; JUN 21-24, 2021; Silverthorne, CO, US. 2021. [Poster]

 

Krstic, J; Reinisch, I; Schindlmaier, K; Galhuber, M; Nössing, C; Depaoli, MR; Ramadani-Muja, J; Chiozzi, R. Z; Heck, A.J.R; Huch, M; Malli, R; Prokesch, A Fasting sensitizes hepatocellular carcinoma to sorafenib by curtailing metabolic flexibility
Tumor Metabolism and the Microenvironment; JAN 25-28, 2021; Virtual Keystone Symposium. 2021. [Onlinepräsentation]
FullText

 

Krstic, J; Reinisch I; Schindlmaier K; Nössing C; Depaoli MR; Ramadani-Muja J; Galhuber M; Zenezini Chiozi R; Heck AJR; Huch M; Malli R; Prokesch A Targeting metabolic flexibility to overcome therapy resistance in hepatocellular carcinoma
12th Annual ÖGMBT Meeting – Biomolecules in/for the 21stCentury; MAR 9, 2021; Vienna, AUSTRIA. 2021. [Oral Communication]
FullText

 

© Med Uni Graz Impressum